Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 3Lung Neoplasms 3Colitis 3Urogenital Neoplasms 2Solid Carcinoma 2Diarrhea 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1Gastrointestinal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Advanced Gastric Cancer 1

Interventions

Drug Therapy 2trastuzumab deruxtecan 1spartalizumab 1sacituzumab govitecan 1Radiotherapy 1Nivolumab 1Interleukin-2 1Fecal Microbiota Transplantation 1Docetaxel 1Cyclophosphamide 1Cisplatin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Drug-Related Side Effects and Adverse Reactions × Fecal Microbiota Transplantation × Clear all
NCT07319364 2026-01-06

A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1 Recruiting
90 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡